Please login to the form below

Not currently logged in

Cardioxyl Pharma

This page shows the latest Cardioxyl Pharma news and features for those working in and with pharma, biotech and healthcare.

BMS agrees to buy Cardioxyl for heart failure drug

BMS agrees to buy Cardioxyl for heart failure drug

Willpay up to $2bn for the US-based company. BMS has agreed to buy Cardioxyl Pharma in a transaction valued at up to $2bn that would give it rights to a ... BMS' agreement with privately-held Cardioxyl reflects an increased focus on heart failure, which

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...